Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ... Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
REFERENCES 184 1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson’s disease. J. Neurosci. 21, 6853– 6861. Bharathi, Vasudevaraju P., Govindaraju M., Palanisamy A. P., Sambamurti K. and Rao K. S. J. (2008) Molecular toxicity of aluminium in relation to neurodegeneration. Indian J. Med. Res. 128, 545–556. Bishop N. J., Robinson M. J., Lendon M., Hewitt C. D., Day J. P. and O'Hara M. (1989) Increased concentration of aluminium in the brain of a parenterally fed preterm infant. Arch. Dis. Child. 64, 1316–1317. Biskup S., Gerlach M., Kupsch A., Reichmann H., Riederer P., Vieregge P., Wüllner U. and Gasser T. (2008) Genes associated with Parkinson syndrome. J. Neurol. 255, 8–17. Björklund L. M., Sánchez-Pemaute R., Chung S., Andersson T., Chen I. Y., McNaught K. S., Brownell A. L., Jenkins B. G., Wahlestedt C., Kim K. S. and Isacson O. (2002) Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc. Natl. Acad. Sci. U. S. A. 99, 2344–2349. Blum-Degen D., Muller T., Kuhn W., Gerlach M., Przuntek H. and Riederer P. (1995) Interleukin- 1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer’s and de novo Parkinson’s disease patients. Neurosci. Lett. 202, 17–20. Boje K. M. (2004) Nitric oxide neurotoxicity in neurodegenerative diseases. Front. Biosci. 9, 763–776. Boka G., Anglade P., Wallach D., Javoy-Agid F., Agid Y. and Hirsch E. C. (1994) Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson’s disease. Neurosci. Lett. 172, 151–154 Bondy S. C. and Kirstein S. (1996) The promotion of iron induced generation of reactive oxygen species in nerve tissue by aluminum. Mol. Chem. Neuropathol. 27, 185–94. Bondy S. C., Ali S. F. and Guo-Ross S. (1998) Aluminum but not iron treatment induces pro- oxidant events in the rat brain. Mol. Chem. Neuropathol. 34, 219–232.
REFERENCES Bonifati V., Rizzu P., van Baren M. J., Schaap O., Breedveld G. J., Krieger E., Dekker M. C., Squitieri F., Ibanez P., Joosse M., van Dongen J. W., Vanacore N., van Swieten J. C., Brice A., Meco G., van Duijn C. M., Oostra B. A. and Heutink P. (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299, 256–259. Borgkvist A., Puelles E., Carta M., Acampora D., Ang S. L., Wurst W., Goiny M., Fisone G., Simeone A. and Usiello A. (2006) Altered dopaminergic innervation and amphetamine response in adult Otx2 conditional mutant mice. Mol. Cell. Neurosci. 31, 293–302. Braak H. and Braak E. (2000) Pathoanatomy of Parkinson’s disease. J. Neurol. 247, II3–II10. Braak H., Del Tredici K., Rüb U., de Vos R. A. I., Jansen Steur E. N. H. and Braak E. (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24, 197–211. Braak H., Bohl J. R., Müller C. M., Rüb U., de Vos R. A. and Del Tredici K. (2006) Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered. Mov. Disord. 21, 2042–2051. Braak H. and Del Tredici K. (2008) Invited Article: Nervous system pathology in sporadic Parkinson disease. Neurology 70, 1916–1925. Brand M. D., Affourtit C., Esteves T. C., Green K., Lambert A. J., Miwa S., Pakay J. L. and Parker N. (2004) Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins. Free Radic. Biol. Med. 37, 755–767. Brooks A. I., Chadwick C. A., Gelbard H. A., Cory-Slechta D. A. and Federoff H. J. (1999) Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss. Brain Res. 823, 1–10. Brusewitz S. (1984) Aluminum, Vol 203. Stockholm, Sweden, University of Stockholm Institute of Theoretical Physics. Burns R. S., Chiueh C. C., Markey S. P., Ebert M. H., Jacobowitz D. M., Kopin I. J. (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars 185
- Page 158 and 159: CHAPTER 3 hippocampus, showed simil
- Page 160 and 161: CHAPTER 3 assume that the distinct
- Page 162 and 163: CHAPTER 3 Fig. 1 Levels of TBARS (A
- Page 164 and 165: CHAPTER 3 Fig. 2 Enzyme activity of
- Page 166 and 167: CHAPTER 3 Fig. 3 Microphotographs s
- Page 168 and 169: CHAPTER 3 Fig. 5 Levels of TBARS (A
- Page 170 and 171: CHAPTER 3 Fig. 6 In vitro effects o
- Page 173: SUMMARY
- Page 176 and 177: SUMMARY values were attained at 48
- Page 178 and 179: SUMMARY neurodegeneration in the DA
- Page 181 and 182: CONCLUSIONS The results obtained in
- Page 183: 13) Aluminium does affect neither M
- Page 187 and 188: RESUMEN RESUMEN Desde el punto de v
- Page 189 and 190: RESUMEN zonas cerebrales excepto en
- Page 191: CONCLUSIONES
- Page 194 and 195: CONCLUSIONES Capítulo 2 4) La admi
- Page 196 and 197: CONCLUSIONES 172 En base a las conc
- Page 199 and 200: Publications as a direct result fro
- Page 201: REFERENCES
- Page 204 and 205: REFERENCES Agil A., Duran R., Barre
- Page 206 and 207: REFERENCES Baquet Z. C., Bickford P
- Page 210 and 211: REFERENCES 186 compacta of the subs
- Page 212 and 213: REFERENCES Chung K. K., Dawson V. L
- Page 214 and 215: REFERENCES Davies K. J. (2001) Degr
- Page 216 and 217: REFERENCES Dhillon A. S., Tarbutton
- Page 218 and 219: REFERENCES Ekstrand M. I., Falkenbe
- Page 220 and 221: REFERENCES Fleming S. M., Delville
- Page 222 and 223: REFERENCES Ghribi O., Dewitt D. A.,
- Page 224 and 225: REFERENCES Good P. F., Olanow C. W.
- Page 226 and 227: REFERENCES Hamilton E. I., Miniski
- Page 228 and 229: REFERENCES Hirsch E. C., Brandel J.
- Page 230 and 231: REFERENCES Inden M., Kitamura Y., T
- Page 232 and 233: REFERENCES Johnson V. J. and Sharma
- Page 234 and 235: REFERENCES Kim W. G., Mohney R. P.,
- Page 236 and 237: REFERENCES Kuhn W., Winkel R., Woit
- Page 238 and 239: REFERENCES 214 K.D. and Polymeropou
- Page 240 and 241: REFERENCES Maraganore D. M., Lesnic
- Page 242 and 243: REFERENCES McCord J. M. and Fridovi
- Page 244 and 245: REFERENCES Miu A. C. and Benga O. (
- Page 246 and 247: REFERENCES Nair V. D., McNaught K.,
- Page 248 and 249: REFERENCES Onyango I. G. (2008) Mit
- Page 250 and 251: REFERENCES Perez F. A. and Palmiter
- Page 252 and 253: REFERENCES Przedborski S. and Goldm
- Page 254 and 255: REFERENCES Rifat S. L., Eastwood M.
- Page 256 and 257: REFERENCES Rymar V. V., Sasseville
REFERENCES<br />
184<br />
1,2,3,6-tetrahydropyrid<strong>in</strong>e-lesioned macaque model <strong>of</strong> Park<strong>in</strong>son’s disease. J. Neurosci. 21,<br />
6853– 6861.<br />
Bharathi, Vasudevaraju P., Gov<strong>in</strong>daraju M., Palanisamy A. P., Sambamurti K. and Rao K. S. J.<br />
(2008) Molecular toxicity <strong>of</strong> <strong>alum<strong>in</strong>ium</strong> <strong>in</strong> relation to neurodegeneration. Indian J. Med.<br />
Res. 128, 545–556.<br />
Bishop N. J., Rob<strong>in</strong>son M. J., Lendon M., Hewitt C. D., Day J. P. and O'Hara M. (1989) Increased<br />
concentration <strong>of</strong> <strong>alum<strong>in</strong>ium</strong> <strong>in</strong> the bra<strong>in</strong> <strong>of</strong> a parenterally fed preterm <strong>in</strong>fant. Arch. Dis.<br />
Child. 64, 1316–1317.<br />
Biskup S., Gerlach M., Kupsch A., Reichmann H., Riederer P., Vieregge P., Wüllner U. and<br />
Gasser T. (2008) Genes associated with Park<strong>in</strong>son syndrome. J. Neurol. 255, 8–17.<br />
Björklund L. M., Sánchez-Pemaute R., Chung S., Andersson T., Chen I. Y., McNaught K. S.,<br />
Brownell A. L., Jenk<strong>in</strong>s B. G., Wahlestedt C., Kim K. S. and Isacson O. (2002) Embryonic<br />
stem cells develop <strong>in</strong>to functional dopam<strong>in</strong>ergic neurons after transplantation <strong>in</strong> a<br />
Park<strong>in</strong>son rat model. Proc. Natl. Acad. Sci. U. S. A. 99, 2344–2349.<br />
Blum-Degen D., Muller T., Kuhn W., Gerlach M., Przuntek H. and Riederer P. (1995) Interleuk<strong>in</strong>-<br />
1 beta and <strong>in</strong>terleuk<strong>in</strong>-6 are elevated <strong>in</strong> the cerebrosp<strong>in</strong>al fluid <strong>of</strong> Alzheimer’s and de novo<br />
Park<strong>in</strong>son’s disease patients. Neurosci. Lett. 202, 17–20.<br />
Boje K. M. (2004) Nitric oxide <strong>neurotoxicity</strong> <strong>in</strong> neurodegenerative diseases. Front. Biosci. 9,<br />
763–776.<br />
Boka G., Anglade P., Wallach D., Javoy-Agid F., Agid Y. and Hirsch E. C. (1994)<br />
Immunocytochemical analysis <strong>of</strong> tumor necrosis factor and its receptors <strong>in</strong> Park<strong>in</strong>son’s<br />
disease. Neurosci. Lett. 172, 151–154<br />
Bondy S. C. and Kirste<strong>in</strong> S. (1996) The promotion <strong>of</strong> iron <strong>in</strong>duced generation <strong>of</strong> reactive oxygen<br />
species <strong>in</strong> nerve tissue by alum<strong>in</strong>um. Mol. Chem. Neuropathol. 27, 185–94.<br />
Bondy S. C., Ali S. F. and Guo-Ross S. (1998) Alum<strong>in</strong>um but not iron treatment <strong>in</strong>duces pro-<br />
oxidant events <strong>in</strong> the rat bra<strong>in</strong>. Mol. Chem. Neuropathol. 34, 219–232.
Change language